Matches in SemOpenAlex for { <https://semopenalex.org/work/W2905085764> ?p ?o ?g. }
- W2905085764 endingPage "3058.e4" @default.
- W2905085764 startingPage "3047" @default.
- W2905085764 abstract "Highly glycolytic cancer cells prevent intracellular acidification by excreting the glycolytic end-products lactate and H+ via the monocarboxylate transporters 1 (MCT1) and 4 (MCT4). We report that syrosingopine, an anti-hypertensive drug, is a dual MCT1 and MCT4 inhibitor (with 60-fold higher potency on MCT4) that prevents lactate and H+ efflux. Syrosingopine elicits synthetic lethality with metformin, an inhibitor of mitochondrial NADH dehydrogenase. NAD+, required for the ATP-generating steps of glycolysis, is regenerated from NADH by mitochondrial NADH dehydrogenase or lactate dehydrogenase. Syrosingopine treatment leads to high intracellular lactate levels and thereby end-product inhibition of lactate dehydrogenase. The loss of NAD+ regeneration capacity due to combined metformin and syrosingopine treatment results in glycolytic blockade, leading to ATP depletion and cell death. Accordingly, ATP levels can be partly restored by exogenously provided NAD+, the NAD precursor nicotinamide mononucleotide (NMN), or vitamin K2. Thus, pharmacological inhibition of MCT1 and MCT4 combined with metformin treatment is a potential cancer therapy." @default.
- W2905085764 created "2018-12-22" @default.
- W2905085764 creator A5003476561 @default.
- W2905085764 creator A5005842057 @default.
- W2905085764 creator A5009403375 @default.
- W2905085764 creator A5018670317 @default.
- W2905085764 creator A5027224657 @default.
- W2905085764 creator A5029920309 @default.
- W2905085764 creator A5037940437 @default.
- W2905085764 creator A5060594687 @default.
- W2905085764 creator A5082438939 @default.
- W2905085764 creator A5089700251 @default.
- W2905085764 date "2018-12-01" @default.
- W2905085764 modified "2023-10-14" @default.
- W2905085764 title "Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells" @default.
- W2905085764 cites W1493753651 @default.
- W2905085764 cites W1551848857 @default.
- W2905085764 cites W1641717686 @default.
- W2905085764 cites W1964959571 @default.
- W2905085764 cites W1997722072 @default.
- W2905085764 cites W2015088299 @default.
- W2905085764 cites W2017007251 @default.
- W2905085764 cites W2020369202 @default.
- W2905085764 cites W2026138483 @default.
- W2905085764 cites W2027786827 @default.
- W2905085764 cites W2040789365 @default.
- W2905085764 cites W2060878129 @default.
- W2905085764 cites W2062459035 @default.
- W2905085764 cites W2068045057 @default.
- W2905085764 cites W2070719504 @default.
- W2905085764 cites W2100693468 @default.
- W2905085764 cites W2115749410 @default.
- W2905085764 cites W2127675410 @default.
- W2905085764 cites W2134787700 @default.
- W2905085764 cites W2138281508 @default.
- W2905085764 cites W2164678001 @default.
- W2905085764 cites W2165235603 @default.
- W2905085764 cites W2167195670 @default.
- W2905085764 cites W2171100237 @default.
- W2905085764 cites W2309526470 @default.
- W2905085764 cites W2336052913 @default.
- W2905085764 cites W2336831152 @default.
- W2905085764 cites W2342466981 @default.
- W2905085764 cites W2343498243 @default.
- W2905085764 cites W2344446983 @default.
- W2905085764 cites W2519020116 @default.
- W2905085764 cites W2530859476 @default.
- W2905085764 cites W2537551256 @default.
- W2905085764 cites W2565024290 @default.
- W2905085764 cites W2703178600 @default.
- W2905085764 cites W2763979809 @default.
- W2905085764 cites W2775008495 @default.
- W2905085764 cites W2791194016 @default.
- W2905085764 cites W788233009 @default.
- W2905085764 doi "https://doi.org/10.1016/j.celrep.2018.11.043" @default.
- W2905085764 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6302548" @default.
- W2905085764 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30540938" @default.
- W2905085764 hasPublicationYear "2018" @default.
- W2905085764 type Work @default.
- W2905085764 sameAs 2905085764 @default.
- W2905085764 citedByCount "207" @default.
- W2905085764 countsByYear W29050857642019 @default.
- W2905085764 countsByYear W29050857642020 @default.
- W2905085764 countsByYear W29050857642021 @default.
- W2905085764 countsByYear W29050857642022 @default.
- W2905085764 countsByYear W29050857642023 @default.
- W2905085764 crossrefType "journal-article" @default.
- W2905085764 hasAuthorship W2905085764A5003476561 @default.
- W2905085764 hasAuthorship W2905085764A5005842057 @default.
- W2905085764 hasAuthorship W2905085764A5009403375 @default.
- W2905085764 hasAuthorship W2905085764A5018670317 @default.
- W2905085764 hasAuthorship W2905085764A5027224657 @default.
- W2905085764 hasAuthorship W2905085764A5029920309 @default.
- W2905085764 hasAuthorship W2905085764A5037940437 @default.
- W2905085764 hasAuthorship W2905085764A5060594687 @default.
- W2905085764 hasAuthorship W2905085764A5082438939 @default.
- W2905085764 hasAuthorship W2905085764A5089700251 @default.
- W2905085764 hasBestOaLocation W29050857641 @default.
- W2905085764 hasConcept C104317684 @default.
- W2905085764 hasConcept C134018914 @default.
- W2905085764 hasConcept C149011108 @default.
- W2905085764 hasConcept C181199279 @default.
- W2905085764 hasConcept C185592680 @default.
- W2905085764 hasConcept C20251656 @default.
- W2905085764 hasConcept C2776317432 @default.
- W2905085764 hasConcept C2776901170 @default.
- W2905085764 hasConcept C2777088662 @default.
- W2905085764 hasConcept C2777318727 @default.
- W2905085764 hasConcept C2779306644 @default.
- W2905085764 hasConcept C2779728014 @default.
- W2905085764 hasConcept C2780323712 @default.
- W2905085764 hasConcept C2781217356 @default.
- W2905085764 hasConcept C28859421 @default.
- W2905085764 hasConcept C55493867 @default.
- W2905085764 hasConcept C62231903 @default.
- W2905085764 hasConcept C75520062 @default.
- W2905085764 hasConcept C79879829 @default.
- W2905085764 hasConcept C86803240 @default.